- Home
- NPCT vs LFCR Comparison
NPCT vs LFCR Comparison
Compare NPCT & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NPCT
- LFCR
- Stock Information
- Founded
- NPCT 2020
- LFCR 1986
- Country
- NPCT United States
- LFCR United States
- Employees
- NPCT N/A
- LFCR N/A
- Industry
- NPCT Investment Managers
- LFCR Biotechnology: Pharmaceutical Preparations
- Sector
- NPCT Finance
- LFCR Health Care
- Exchange
- NPCT Nasdaq
- LFCR Nasdaq
- Market Cap
- NPCT 313.7M
- LFCR 308.8M
- IPO Year
- NPCT N/A
- LFCR N/A
- Fundamental
- Price
- NPCT $10.91
- LFCR $7.61
- Analyst Decision
- NPCT
- LFCR Buy
- Analyst Count
- NPCT 0
- LFCR 4
- Target Price
- NPCT N/A
- LFCR $8.00
- AVG Volume (30 Days)
- NPCT 107.1K
- LFCR 108.3K
- Earning Date
- NPCT 01-01-0001
- LFCR 08-07-2025
- Dividend Yield
- NPCT 9.82%
- LFCR N/A
- EPS Growth
- NPCT N/A
- LFCR N/A
- EPS
- NPCT N/A
- LFCR N/A
- Revenue
- NPCT N/A
- LFCR $128,867,000.00
- Revenue This Year
- NPCT N/A
- LFCR $4.78
- Revenue Next Year
- NPCT N/A
- LFCR $12.02
- P/E Ratio
- NPCT N/A
- LFCR N/A
- Revenue Growth
- NPCT N/A
- LFCR 0.47
- 52 Week Low
- NPCT $8.58
- LFCR $3.68
- 52 Week High
- NPCT $10.63
- LFCR $8.85
- Technical
- Relative Strength Index (RSI)
- NPCT 48.99
- LFCR 53.94
- Support Level
- NPCT $10.82
- LFCR $7.33
- Resistance Level
- NPCT $10.98
- LFCR $7.73
- Average True Range (ATR)
- NPCT 0.12
- LFCR 0.30
- MACD
- NPCT -0.01
- LFCR 0.03
- Stochastic Oscillator
- NPCT 48.15
- LFCR 65.33
About NPCT Nuveen Core Plus Impact Fund of Beneficial Interest
Nuveen Core Plus Impact Fund is an organized, diversified, closed-end management investment company. The Fund's investment objective is to seek total return through high current income and capital appreciation, while giving special consideration to certain impact and environmental, social and governance criteria.
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.